2SADLER J E. Von Willebrand factor,ADAMTS13,and thrombotic thrombocytopenic purpura[J]. Blood,2008,112:11-18.
3SADLER J E, PONCZ M. Antibody-mediated throm-botic disorders : thrombotic thrombocytopenic purpuraand heparin-induced thrombocytopenia[M]//KAUS-HANSKY K,LICHTMAN M A’BEULTER E,et al.Williams Hematology. 8th ed. The McGraw-HillCompanies. Inc,2010:2163 - 2183.
4KOKAME K,NOBE Y’KOKUBO Y,et al. FRETS-VWF73,a first fluorogenic substrate for ADAMTS13assay[J]. Br J Haematol, 2005,129 :93 -100.
5BRESIN E,GASTOLDI S,DAINA E,et al. Ritux-imab as pre-emptive treatment in patients with throm-botic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies [J]. Thromb Haemost,2009,101:233-238.
6Tsai HM. The molecular biology of thrombotic microa giopathy [ J ]. Kidney Int,2006,70 ( 1 ) : 16-23.
7Hughes E, Brown J, Collins J J, et al. Ovulation suppression for endometriosis [ J ]. Cochrane Database Syst Rev, 2007, ( 3 ) : CD000155.